A bereavement support group intervention affects plasma burden of human immunodeficiency virus type 1 - Report of a randomized controlled trial

Journal of Human Virology

Volumn 4, Issue 1, 2001, Pages 44-54

  Goodkin, K ^a   Baldewicz, T T ^a   Asthana, D ^a   Khamis, I ^a   Blaney, N T ^a   Kumar, M ^a   Burkhalter, J E ^a   Leeds, B ^a   Shapshak, P ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

AIDS; Behavior; Bereavement; HAART; HIV; Stress; Support; Therapy; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ARTICLE; ASSAY; BEREAVEMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISTRESS SYNDROME; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LYMPHOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUPPORT GROUP; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; HIV INFECTIONS; HIV-1; HOSPICE CARE; HUMANS; MALE; RNA, VIRAL; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0035140404     PISSN: 10909508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Life stressors and coping style are associated with immune measures in HIV-1 infection: A preliminary report
2. Stress-associated reductions of cytotoxic T lymphocytes and natural killer cells in asymptomatic HIV infection
3. Social support and the development of immune function in human immunodeficiency virus infection
4. Active coping style is associated with natural killer cell cytotoxicity in asymptomatic HIV-1 seropositive homosexual men
5. Depressive symptoms and CD4 lymphocyte decline among HIV-infected men
6. Effects of AIDS-related bereavement on HIV progression among New York City gay men
7. Immune system changes after the death of a partner in HIV-positive gay men
8. Bereavement is associated with time-dependent decrements in cellular immune function in asymptomatic HIV-1 seropositive homosexual men
9. Clinical aspects of psychoneuroimmunology
10. A bereavement support group intervention is longitudinally associated with salutary effects on CD4 cell count and on number of physician visits
11. Depressive symptoms as predictors of medical outcomes in HIV infection
12. A randomized controlled trial of a bereavement support group intervention in human immunodeficiency virus type 1-seropositive and seronegative homosexual men
13. + lymphocytes as prognostic markers of HIV-1 infection
14. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
15. Cell-associated infectious HIV-1 viral load as a predictor of clinical progression and survival among HIV-1 infected injection drug users and homosexual men
16. HIV viral load markers in clinical practice
17. Recovery of the immune system with antiretroviral therapy: The end of opportunism?
18. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
19. Co-infection with opportunistic pathogens promotes human immunodeficiency virus type 1 infection in macrophages
20. Bereavement support group techniques for the HIV infected: Integration of research with clinical practice
21. Quality assessment and improvement in group psychotherapy
22. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: Application to acute retroviral infection
23. Use of whole blood methods in assessment of immune parameters in immunodeficiency states
24. Thrush and fever as measures of immunocompetence in HIV-1 infected men
25. Dissociation of immunologic and virologic responses to highly active antiretroviral therapy
26. An immunoendocrinological hypothesis of HIV infection
27. In vitro restoration of T cell immune function in human immunodeficiency virus-positive persons: Effects of interleukin (IL)-12 and anti-IL-10
28. Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro
29. Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type-1 positive subjects
30. A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection
31. Alloimmunization for immune-based therapy and vaccine design against HIV/AIDS
32. Structured treatment interruptions to control HIV-1 infection [letter]
33. Potent and synergistic_neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12
34. Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells
35. The CRH stimulation test in bereaved subjects with and without accompanying depression
36. A molecular mechanism for stress-induced alterations in susceptibility to disease
37. The HIV-1 virion-associated protein Vpr is a coactivator of the human glucocorticoid receptor
38. HIV-1 infection, neuroendocrine abnormalities, and clinical outcomes
39. Identification of a novel glucocorticoid response element within the genome of human immunodeficiency virus type 1
40. Disparities in psychological, neuroendocrine, and immunologic patterns in HIV-1 seropositive and seronegative gay men
41. Longitudinal evaluation of adrenocortical function in patients infected with the human immunodeficiency virus
42. Prevalence of cortisol deficiency in late HIV disease
43. Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy
44. Improved conditions for extraction and amplification of human immunodeficiency virus from plasma samples with low viral load